10 records totalling $8,415,783.00 CAD, from official Government of Canada open data.
| Canadian Institutes of Health Research | $8,415,783 | 10 records |
Genomic and Outcomes Databank for Pharmacogenomic and Implementation Studies (GoPGx)
SEARCH (active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare) & PREVENT (Pharmacogenomics of Adverse Reaction EVEnts National Team)
DSEN active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare (DSEN SEARCH)
DSEN active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare (DSEN SEARCH)
Domperidone to stimulate milk production during lactation and potential risk of serious ventricular arrhythmia and/or sudden cardiac death.
Optimizing Chronic Hepatitis C Treatment Using Pharmacogenomic Biomarkers
5-HT3 Antagonists (Antiemetics) & Cardiac Safety, Using an Active Surveillance Approach
Active Surveillance for evaluation of harm of direct acting oral anticoagulants (DOACs) in real-world patients
Development of clinical practice guidelines for pharmacogenetic testing
Severe Cutaneous Adverse Drug Reactions (SCAR) 2019 International Meeting: From Science to Translation